SYRE logo

Spyre Therapeutics (SYRE) Non Current Assets

Annual Non Current Assets

$331.00 K
-$8.55 M-96.28%

31 December 2023

SYRE Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$10.00 K
-$321.00 K-96.98%

30 September 2024

SYRE Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SYRE Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--97.0%
3 y3 years-97.0%-99.9%
5 y5 years-96.2%-99.9%

SYRE Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-97.0%at low-99.9%at low
5 y5 years-97.2%at low-99.9%at low
alltimeall time-97.2%-99.9%at low

Spyre Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$10.00 K(-97.0%)
June 2024
-
$331.00 K(+0.6%)
Mar 2024
-
$329.00 K(-0.6%)
Dec 2023
$341.53 M(+448.6%)
$331.00 K(-74.8%)
Sept 2023
-
$1.32 M(-63.9%)
June 2023
-
$3.64 M(-54.9%)
Mar 2023
-
$8.08 M(-9.1%)
Dec 2022
$62.26 M(-37.0%)
-
Dec 2022
-
$8.89 M(-4.9%)
Sept 2022
-
$9.35 M(-7.1%)
June 2022
-
$10.06 M(-4.9%)
Mar 2022
-
$10.57 M(-4.2%)
Dec 2021
$98.89 M(-34.0%)
$11.04 M(-4.4%)
Sept 2021
-
$11.55 M(-8.5%)
June 2021
-
$12.61 M(+3.4%)
Mar 2021
-
$12.20 M(+3.2%)
Dec 2020
$149.79 M(+101.0%)
$11.83 M(+5.3%)
Sept 2020
-
$11.23 M(+1.7%)
June 2020
-
$11.04 M(+5.0%)
Mar 2020
-
$10.52 M(+21.2%)
Dec 2019
$74.50 M
$8.68 M(+16.2%)
DateAnnualQuarterly
Sept 2019
-
$7.47 M(-1.2%)
June 2019
-
$7.56 M(+344.4%)
Mar 2019
-
$1.70 M(+59.3%)
Dec 2018
$76.67 M(+39.4%)
$1.07 M(+19.3%)
Sept 2018
-
$895.00 K(+8.5%)
June 2018
-
$825.00 K(-12.5%)
Mar 2018
-
$943.00 K(-13.2%)
Dec 2017
$54.99 M(-17.2%)
$1.09 M(+10.5%)
Sept 2017
-
$983.00 K(+4.5%)
June 2017
-
$941.00 K(-2.2%)
Mar 2017
-
$962.00 K(+50.5%)
Dec 2016
$66.42 M(+73.5%)
$639.00 K(+67.3%)
Sept 2016
-
$382.00 K(-3.3%)
June 2016
-
$395.00 K(+16.5%)
Mar 2016
-
$339.00 K(-7.9%)
Dec 2015
$38.29 M(+1302.4%)
$368.00 K(-1.9%)
Sept 2015
-
$375.00 K(+40.4%)
June 2015
-
$267.00 K(+4.7%)
Mar 2015
-
$255.00 K(+27.5%)
Dec 2014
$2.73 M(-40.6%)
$200.00 K
Dec 2013
$4.60 M
-

FAQ

  • What is Spyre Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Spyre Therapeutics?
  • What is Spyre Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Spyre Therapeutics?
  • What is Spyre Therapeutics quarterly non current assets year-on-year change?

What is Spyre Therapeutics annual long term assets?

The current annual non current assets of SYRE is $331.00 K

What is the all time high annual non current assets for Spyre Therapeutics?

Spyre Therapeutics all-time high annual long term assets is $11.83 M

What is Spyre Therapeutics quarterly long term assets?

The current quarterly non current assets of SYRE is $10.00 K

What is the all time high quarterly non current assets for Spyre Therapeutics?

Spyre Therapeutics all-time high quarterly long term assets is $12.61 M

What is Spyre Therapeutics quarterly non current assets year-on-year change?

Over the past year, SYRE quarterly long term assets has changed by -$321.00 K (-96.98%)